Nova Patents
DK2361609T3

Sustained release small molecule drug formulation

Abstract

This record has no abstract on file.

Term

0 yearsto projected expiry

Projected expiry 28 September 2026, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

38 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
72284505United States of AmericaP
06825283European Patent Office (EPO)A

Members38

Family members, oldest first
DocumentOfficeKind
US2007077304A1United States of AmericaA1
AU2006299657A1AustraliaA1
CA2624088A1CanadaA1
WO2007041410A2World Intellectual Property Organization (WIPO)A2
WO2007041410A3World Intellectual Property Organization (WIPO)A3
AR056554A1ArgentinaA1
TW200803920ATaiwan Province of ChinaA
EP1940351A2European Patent Office (EPO)A2
CN101365423AChinaA
JP2009510116AJapanA
EP2361609A1European Patent Office (EPO)A1
EP1940351B1European Patent Office (EPO)B1
ATE551989T1AustriaT1
DK1940351T3DenmarkT3
ES2385384T3SpainT3
CN101365423BChinaB
AU2006299657B2AustraliaB2
EP2361609B1European Patent Office (EPO)B1
DK2361609T3This recordDenmarkT3
ES2422681T3SpainT3
PL2361609T3PolandT3
JP2014012712AJapanA
US2014086990A1United States of AmericaA1
US8852638B2United States of AmericaB2
US9044450B2United States of AmericaB2
US2015231258A1United States of AmericaA1
CA2624088CCanadaC
IL190499AIsraelA
JP5934685B2JapanB2
JP2016128411AJapanA
US9597402B2United States of AmericaB2
US2017239252A1United States of AmericaA1
JP6216364B2JapanB2
US10058554B2United States of AmericaB2
US2018325905A1United States of AmericaA1
US10406160B2United States of AmericaB2
US2020046704A1United States of AmericaA1
US11110093B2United States of AmericaB2